Abstract
Class I recalls possess the greatest degree of health hazard and are frequently conducted to the consumer or user level. This study analyzes all Class I recalls appearing in the Food and Drug Administration (FDA) Enforcement Reports from 1982–1996. Major causes of Class I recalls over the past 14 years include: drug quality and good manufacturing practices (GMP) violations, mislabeling, and adverse reactions. Class 1 recalls over this time period are analyzed by reason, brand versus generic company, dosage form (eg, injection, tablet), notification method, and further FDA enforcement action (eg, seizure, injunction, criminal prosecution). Trends are identified. Finally, the effectiveness of Class I recalls to the pharmacy level is assessed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
43 Federal Register 26202 (1978).
Fine SD. Recalls—Definition and exposition. Food Drug Cosmetic Law J. 1972;27:662–671.
Harper BM. Mandatory food and drug recalls. An analysis of a developing FDA enforcement tool. Food Drug Cosmetic Law J. 1981;35:669–687.
Rumore MM. The drug product recall system and the pharmacist: Are consumers protected? N. Y. State J. Health Syst Pharm. 1996;15(10):137–159.
FDA Enforcement Manual. Tab 600. Recalls and administrative injunction. Thompson Publications Group, Inc.; 1992:44.
FDA Regulatory Procedures Manual. Part 5, Ch. 5.00-20. Recall and emergency procedures.
Clevenger WL. Recalls. Food, Drug, Cosmetic Law J. 1972;27:332–343.
Parker BR, Valentino G. Handling a pharmaceutical recall: why it pays to do it right. Drug lnf J. 1994; 28:899–813.
Labeling/packaging error recalls down 43% in 1996. The Pink Sheet. T&G 6–7, January 20, 1997.
FDA seeks labeling regulation changes, disclosure of clinical trials in preliminary legislative agenda. FDC Reports—The Pink Sheet. 59(11):3–4, March 17, 1997.
Gumbhir AK, Jamison ML. Assessing the effectiveness of drug recalls in pharmacies. Drug & Cosmetic Ind. 1975;117:40–43, 113.
U.S.P. Quality Review. The U.S.P. Convention. 8/96.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rumore, M.M. An Analysis of Class I Recalls: 1982–1996. Ther Innov Regul Sci 32, 65–71 (1998). https://doi.org/10.1177/009286159803200109
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286159803200109